PLENARY KEYNOTE SESSIONS
MONDAY, MAY 13 | 4:25 - 5:20 PM
Driving New CAR T Cells
Marcela V. Maus, MD, PhD, Associate Professor, Medicine; Director, Cellular Immunotherapy, Massachusetts General Hospital
5:20 – 6:05 PM
PEGS 2024 YOUNG SCIENTIST KEYNOTE
High-throughput Discovery of Protein Folding Stability and Dynamics
Gabriel J. Rocklin, PhD, Assistant Professor, Pharmacology, Northwestern University
TUESDAY, MAY 14 | 10:10 - 11:00 AM
Base Editing and Prime Editing: Engineered Proteins that Precisely Correct Pathogenic Mutations in Cells, Animals, and Patients
David R. Liu, PhD, Richard Merkin Professor and Director, Merkin Institute of Transformative Technologies in Healthcare; Broad Institute Core Institute Member and Vice-Chair of the Faculty; Director of the Chemical Biology and Therapeutic Sciences Program; Howard Hughes Medical Institute Investigator; Thomas Dudley Cabot Professor of the Natural Sciences and Professor of Chemistry and Chemical Biology, Harvard University
THURSDAY, MAY 16 | 12:00 - 12:55 PM
Plenary Fireside Chat: What Comes Next in Antibody Discovery and Engineering?
Moderator:
K. Dane Wittrup, PhD, C.P. Dubbs Professor, Chemical Engineering & Bioengineering, Massachusetts Institute of Technology
Panelists:
Paul J. Carter, PhD, Genentech Fellow, Antibody Engineering, Genentech
Daniel Chen, MD, PhD, Founder, Engenuity Life Sciences
Jane K. Osbourn, PhD, CSO, Alchemab Therapeutics Ltd.